Latest filing published 16 Apr 2026 for 와이바이오로직스, €340k.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -70.2%Entry ₩25,600 · Close 08 Oct 2026 ₩7,630
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
장우익: trading record in brief
장우익, listed as chief executive, appears in our data through filings on 와이바이오로직스 shares, published by DART (FSS). Between 18 December 2025 and 9 April 2026, the trades on record add up to 3 filings.
The open-market side counts 2 purchases for €340k alongside 1 sale. The totals exclude 2 filings filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2026: 1 purchase and no sales on the market.
The record was last updated on 16 April 2026 with an open-market purchase (€340k) in 와이바이오로직스. This summary is built from DART (FSS) disclosures alone and does not predict where the share price will go.
Companies and markets linked to 장우익
Open company profiles for insider transactions, fundamentals and analyst consensus when available.